Trials / Recruiting
RecruitingNCT04343365
Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board
Feasibility of Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board in Cancer Patients
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (estimated)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the ability of a multidisciplinary group, the Evolutionary Tumor Board (ETB), to develop therapeutic strategies in patients without curative options.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Evolutionary Tumor Board (ETB) | The ETB consists of evolutionary biologists, mathematicians, research scientists, statisticians,data scientists, radiologists, pathologists, oncologists (surgical, radiation, medical, and pediatric), and clinical trial coordinators.The ETB will generate hypotheses, mathematical models, and experiments from the discussion towards further integration of evolutionary ideas towards therapeutic strategies for participants. The ETB will collect data through a chart review regarding adherence and results of ETB recommendation |
Timeline
- Start date
- 2020-05-05
- Primary completion
- 2028-03-01
- Completion
- 2028-03-01
- First posted
- 2020-04-13
- Last updated
- 2026-04-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04343365. Inclusion in this directory is not an endorsement.